The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Mechanisms of Mononuclear Phagocyte Recruitment in Alzheimers Disease
Open accessAbstract
Alzheimer's disease (AD) is associated with a significant neuroinflammatory component. Mononuclear phagocytes including monocytes and microglia are the principal cells involved, and they accumulate at perivascular sites of beta-amyloid (Abeta) deposition and in senile plaques. Recent evidence suggests that mononuclear phagocyte accumulation in the AD brain is dependent on chemokines. CCL2, a major monocyte chemokine, is upregulated in the AD brain. Interaction of CCL2 with its receptor CCR2 regulates mononuclear phagocyte accumulation in a mouse model of AD. CCR2 deficiency leads to lower mononuclear phagocyte accumulation and is associated with higher brain Abeta levels, specifically around blood vessels, suggesting that monocytes accumulate at sites of Abeta deposition in an initial attempt to clear these deposits and stop or delay their neurotoxic effects. Indeed, enhancing mononuclear phagocyte accumulation delays progression of AD. Here we review the mechanisms of mononuclear phagocyte accumulation in AD and discuss the potential roles of additional chemokines and their receptors in this process. We also propose a multi-step model for recruitment of mononuclear phagocytes into the brain. The first step involves egress of monocyte/microglial precursors from the bone marrow into the blood. The second step is crossing the blood-brain barrier to the perivascular areas and into the brain parenchyma. The final step includes movement of monocytes/microglia from areas of the brain that lack any amyloid deposition to senile plaques. Understanding the mechanism of recruitment of mononuclear phagocytes to the AD brain is necessary to further understand the role of these cells in the pathogenesis of AD and to identify any potential therapeutic use of these cells for the treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“CX3CR1 is a chemokine receptor expressed on microglia and a subset of monocytes (8, 9).”
From Heterozygous CX3CR1 Deficiency in Microglia Restores Neuronal β-Amyloid Clearance Pathways and Slows Progression of Alzheimer's Like-Disease in PS1-APP Mice (2019) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Monitoring of Blood Vessels and Tissues by a Population of Monocytes with Patrolling Behavior
Auffray, C., Fogg, D., Garfa, M., Elain, G., Join-Lambert, O., Kayal, S., Sarnacki, S., Cumano, A., Lauvau, G., & Geissmann, F. (2007) · Science · doi:10.1126/science.1142883 · Cited by 1,973
Serbina, N. V., & Pamer, E. G. (2006) · Nature Immunology · doi:10.1038/ni1309 · Cited by 1,658
Local self-renewal can sustain CNS microglia maintenance and function throughout adult life
Ajami, B., Bennett, J. L., Krieger, C., Tetzlaff, W., & Rossi, F. M. V. (2007) · Nature Neuroscience · doi:10.1038/nn2014 · Cited by 1,643
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Simard, A. R., Soulet, D., Gowing, G., Julien, J.-P., & Rivest, S. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.022 · Cited by 1,265
Tsou, C.-L., Peters, W., Si, Y., Slaymaker, S., Aslanian, A. M., Weisberg, S. P., Mack, M., & Charo, I. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29919 · Cited by 1,152
Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions
Mildner, A., Schmidt, H., Nitsche, M., Merkler, D., Hanisch, U.-K., Mack, M., Heikenwalder, M., Brück, W., Priller, J., & Prinz, M. (2007) · Nature Neuroscience · doi:10.1038/nn2015 · Cited by 1,089
Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice
Eglitis, M. A., & Mezey, É. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4080 · Cited by 1,015
El Khoury, J., Toft, M., Hickman, S. E., Means, T. K., Terada, K., Geula, C., & Luster, A. D. (2007) · Nature Medicine · doi:10.1038/nm1555 · Cited by 915
Self-citationMechanisms of Disease: astrocytes in neurodegenerative disease
Maragakis, N. J., & Rothstein, J. D. (2006) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0355 · Cited by 836
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–120 of 120
Zhang, B., Xu, B., Zhang, R., Gong, B., & Guo, J. (2025) · BMC Neurology · doi:10.1186/s12883-025-04155-y · Cited by 3
APOE, Inflammation, and T Cells in Translational Disease Models and Clinical Medicine
Adlimoghaddam, A., Cervantes, D., & Wheeler, C. J. (2026) · Springer eBooks · doi:10.1007/978-3-031-96089-5_35 · Cited by 1
Li, E., Zhang, P., & Feng, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783786 · Cited by 1
Azizi, G., & Mirshafiey, A. (2016) · Compendium of Inflammatory Diseases · doi:10.1007/978-3-7643-8550-7_98 · Cited by 1
Ohtani, S., Ushiyama, A., Wasoontarajaroen, S., Wãda, K., Suzuki, Y., & Hattori, K. (2024) · Fundamental Toxicological Sciences · doi:10.2131/fts.11.27 · Cited by 1
Microglia and macrophages in central nervous systems
Cho, I. K. H. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-822368-0.00008-6 · Cited by 1
Wang, N., Wei, M., Li, X., Jia, L., Li, J., Xu, H., Zhang, Y., & Zheng, H. (2020) · Research Square · doi:10.21203/rs.3.rs-93476/v1 · Cited by 1
Darlington, D. (2014) · Digital Commons - University of South Florida (University of South Florida)
Azizi, G., & Mirshafiey, A. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_98-2
Azizi, G., & Mirshafiey, A. (2016) · Encyclopedia of Inflammatory Diseases · doi:10.1007/978-3-0348-0620-6_98-1
Cytokines and Chemokines in the Nervous System in Health and Disease
Azizi, G., & Rostami, A. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95702-1.00248-7
ՄԻԿՐՈԳԼԻԱՅԻ ԵՎ ՄՈՆՈՑԻՏՆԵՐԻ ԴԵՐԸ ԱԼՑՀԵՅՄԵՐԻ ՀԻՎԱՆԴՈՒԹՅԱՆ ԶԱՐԳԱՑՄԱՆ ԵՎ ՆԵՅՐՈԲՈՐԲՈՔՄԱՆ ԳՈՐԾԸՆԹԱՑՆԵՐՈՒՄ
Գ.Ա., Կ. (2025) · MEDICINE SCIENCE AND EDUCATION · doi:10.56936/18291775-2025.40-65
APOE, Inflammation, and T Cells in Translational Disease Models and Clinical Medicine
Adlimoghaddam, A., Cervantes, D., & Wheeler, C. J. (2026) · Springer eBooks · doi:10.1007/978-3-031-52641-1_35-1
The role of serotoninergic neurons in amyotrophic lateral sclerosis
Oussini, H. E. (2016) · theses.fr (ABES) · doi:10.70675/2431e8ddzd4e4z4710z81dcz14100daa6294
Du, L., & Yan, J. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107556
Yang, Z., Xiao, Z., Huang, B., & Wang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1955233
Targeting the peripheral immune system for treatment of Alzheimer’s disease
Almasarani, E., Fog, M. H., Vorup‐Jensen, T., & Juul‐Madsen, K. (2026) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-026-00054-9
Metadata
- Authors
- Hickman, S. E., & Khoury, J. E.
- Affiliations
- Harvard University (US)
- ORCID
- Hickman, Suzanne E.
- Venue
- CNS & Neurological Disorders - Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-04-01
- Volume
- 9
- Issue
- 2
- Pages
- 168-173
- ISSN
- 1568-007X (ISSN-L)
- 1871-5273
- PMC
- PMC3684802
- OpenAlex
- W2060964242
- Cited by
- 120
- References
- 59
- Citations by year
- 2026: 8 · 2025: 4 · 2024: 8 · 2023: 4 · 2022: 1 · 2021: 5 · 2020: 9 · 2019: 6 · 2018: 8 · 2017: 11 · 2016: 11 · 2015: 8 · 2014: 12 · 2013: 9 · 2012: 7
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- CNS & Neurological Disorders - Drug Targets (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS059005, R01NS059005)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, mononuclear phagocytes, monocytes, microglia, chemokines, MCP-1, CCR2, amyloid-beta, amyloid plaques, neuroinflammation, blood-brain barrier, monocyte recruitment
- MeSH terms
- Alzheimer Disease, Animals, Chemotaxis, Leukocyte, Encephalitis, Humans, Leukocytes, Mononuclear, Phagocytes, Amyloid beta-Peptides, Chemokine CCL2, Myeloid Progenitor Cells, Mice, Receptors, CCR2, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
